Anxiety Disorders Completed Phase 2 / 3 Trials for St. John's Wort (DB01323)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00118833St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)Treatment